Circulating CD8+CD56-perforin+ T cells are increased in multiple sclerosis patients

Area of Science:

• Immunology
• Neuroimmunology
• T cell biology

Background:

• Multiple Sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
• Understanding the role of specific immune cell populations, like T cells, is crucial for MS pathogenesis.
• Perforin, a cytotoxic protein, is implicated in immune-mediated tissue damage.

Purpose of the Study:

• To investigate the frequency and expression of CD8+CD56-perforin+ T cells in different subtypes of MS.
• To correlate these T cell populations with disease severity, as measured by the Expanded Disability Status Scale (EDSS).

Main Methods:

• Flow cytometry was used to quantify circulating CD8+CD56-perforin+ T cells.
• Analysis included patients with relapsing-remitting MS (RRMS), secondary progressive MS (SPMS), and primary progressive MS (PPMS).
• Comparison was made between MS patient groups and healthy controls, and stratified by EDSS scores (≥3 vs. <3).

Main Results:

• Elevated percentages of CD8+CD56-perforin+ T cells were observed in RRMS, SPMS, and PPMS patients compared to controls.
• Higher perforin expression in CD8+CD56- T cells was noted in relapsing RRMS and PPMS patients versus controls.
• MS patients with EDSS ≥3 exhibited a higher percentage of CD8+CD56-perforin+ T cells than those with EDSS <3 and controls.

Conclusions:

• Multiple Sclerosis is characterized by a dysregulation of CD8+CD56-perforin+ T cells.
• This T cell subpopulation may play a significant role in the development and progression of MS-related disability.
• Targeting these aberrant T cells could offer potential therapeutic strategies for MS.